When the COVID-19 pandemic hit in early 2020, fine wine’s downturn was both shorter and less severe than most mainstream financial assets. At its 2020 low on March 21, the Liv-ex 1000, one of the broadest fine wine market’s benchmark indices, had only declined by 4% compared with double-digit losses in most equity markets.
Read the full article here.
